ZA888969B - Acyl derivatives of hydroxy pyrimidines - Google Patents

Acyl derivatives of hydroxy pyrimidines

Info

Publication number
ZA888969B
ZA888969B ZA888969A ZA888969A ZA888969B ZA 888969 B ZA888969 B ZA 888969B ZA 888969 A ZA888969 A ZA 888969A ZA 888969 A ZA888969 A ZA 888969A ZA 888969 B ZA888969 B ZA 888969B
Authority
ZA
South Africa
Prior art keywords
acyl derivatives
hydroxy pyrimidines
substituted
compounds
useful
Prior art date
Application number
ZA888969A
Other languages
English (en)
Inventor
Frederick Judson Walker
Judson Walker Frederick
John Lawrence Lamattina
Lawrence Lamattina John
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA888969B publication Critical patent/ZA888969B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA888969A 1987-12-02 1988-11-30 Acyl derivatives of hydroxy pyrimidines ZA888969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/003171 WO1989005295A1 (en) 1987-12-02 1987-12-02 Acyl derivatives of hydroxypyrimidines

Publications (1)

Publication Number Publication Date
ZA888969B true ZA888969B (en) 1990-07-25

Family

ID=22202696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA888969A ZA888969B (en) 1987-12-02 1988-11-30 Acyl derivatives of hydroxy pyrimidines

Country Status (26)

Country Link
EP (1) EP0319170B1 (xx)
JP (1) JPH0725740B2 (xx)
KR (1) KR910000415B1 (xx)
CN (1) CN1033379A (xx)
AT (1) ATE86983T1 (xx)
AU (1) AU609547B2 (xx)
CA (1) CA1336516C (xx)
DD (1) DD277275A5 (xx)
DE (1) DE3879410T2 (xx)
DK (1) DK671188A (xx)
EG (1) EG19003A (xx)
ES (1) ES2053769T3 (xx)
FI (1) FI893648A0 (xx)
HU (1) HU206203B (xx)
IE (1) IE63456B1 (xx)
IL (1) IL88512A0 (xx)
MX (1) MX14001A (xx)
MY (1) MY103499A (xx)
NO (1) NO893105L (xx)
NZ (1) NZ227163A (xx)
PL (1) PL158165B1 (xx)
PT (1) PT89124B (xx)
RU (1) RU2036909C1 (xx)
WO (1) WO1989005295A1 (xx)
YU (1) YU47013B (xx)
ZA (1) ZA888969B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006718A1 (en) * 1988-12-21 1990-06-28 Massachusetts Institute Of Technology A method for laser induced fluorescence of tissue
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
KR20170057191A (ko) * 2017-05-04 2017-05-24 김점식 유압을 이용한 전기 자동차 구동장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) * 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines

Also Published As

Publication number Publication date
WO1989005295A1 (en) 1989-06-15
HU206203B (en) 1992-09-28
DK671188D0 (da) 1988-12-01
IL88512A0 (en) 1989-06-30
ES2053769T3 (es) 1994-08-01
HUT55003A (en) 1991-04-29
DE3879410T2 (de) 1993-06-24
FI893648A0 (fi) 1989-08-01
JPH01250364A (ja) 1989-10-05
PL276122A1 (en) 1989-06-12
NZ227163A (en) 1990-11-27
EP0319170B1 (en) 1993-03-17
AU2647088A (en) 1989-06-08
EP0319170A2 (en) 1989-06-07
EP0319170A3 (en) 1990-08-01
IE883598L (en) 1989-06-02
PT89124A (pt) 1988-12-01
DK671188A (da) 1989-07-28
DE3879410D1 (de) 1993-04-22
YU47013B (sh) 1994-11-15
MX14001A (es) 1993-06-01
RU2036909C1 (ru) 1995-06-09
NO893105L (no) 1989-09-27
HU894552D0 (en) 1990-11-28
ATE86983T1 (de) 1993-04-15
DD277275A5 (de) 1990-03-28
PT89124B (pt) 1993-04-30
NO893105D0 (no) 1989-08-01
KR910000415B1 (ko) 1991-01-25
KR890009890A (ko) 1989-08-04
AU609547B2 (en) 1991-05-02
EG19003A (en) 1994-06-30
PL158165B1 (pl) 1992-08-31
IE63456B1 (en) 1995-04-19
YU217988A (en) 1990-10-31
CN1033379A (zh) 1989-06-14
JPH0725740B2 (ja) 1995-03-22
MY103499A (en) 1993-06-30
CA1336516C (en) 1995-08-01

Similar Documents

Publication Publication Date Title
ES2000734A6 (es) Un procedimiento para la preparacion de pirimidinas
AU2911489A (en) Quinoline derivatives as antagonists of leukotriene d4
EP0713703A3 (en) Substituted phenylpyrimidine derivatives useful in the treatment or prevention of diseases of the central nervous system
DE69730156D1 (de) 5-Pyrimidinyl-4-yl-imidazole derivatives useful for the treatment of CSBP/RK/p38 mediated diseases
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
IE861997L (en) Zwitterionic bicyclic compounds
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
ATE53837T1 (de) Pyridin-derivate, ihre herstellung und verwendung.
ZA888969B (en) Acyl derivatives of hydroxy pyrimidines
WO2001057042A3 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
NO924290D0 (no) Azabenzimidazoler for behandling av astma, artritt og lignende lidelser
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
IE861565L (en) Polycyclic quinoline derivatives
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
IT1142938B (it) Procedimento per la produzione di imidazo (4,5-b)-piridine e imidazo (4,5-b)-pirimidine
AU8196882A (en) Substituted cyclopropenone for the treatment of alopecia areata and other dermatological diseases
MX5313A (es) Derivados heterociclicos para el tratamiento de trastornos cardiovasculares y procedimiento para obtenerlos.